Core Scientific, Inc Tranche 2 Warrants

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$94,925
$95,354
$141,102
$179,291
Gross Profit
4,763
-156
38,817
77,646
EBITDA
-234,875
-419,362
-758,518
254,750
EBIT
-264,030
-448,053
-789,977
224,984
Net Income
-265,541
-455,259
-804,896
210,691
Net Change In Cash
94,925
95,354
141,102
179,291
Free Cash Flow
-15,184
-25,461
-1,931
-9,720
Cash
836,197
253,019
97,105
114,276
Basic Shares
306,146
292,486
178,505
282,531

Annual Financials

Values in thousands 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Revenue
$510,672
$502,400
$640,313
$544,483
Gross Profit
121,070
123,459
8,400
238,862
EBITDA
-1,156,955
-63,121
167,610
EBIT
-1,277,076
-159,566
134,248
Net Income
-1,315,005
-246,487
-2,146,318
47,312
Net Change In Cash
510,672
502,400
640,313
544,483
Free Cash Flow
-52,065
48,953
-396,470
-116,010
Cash
836,197
50,409
15,884
131,678
Basic Shares
255,832
379,863
375,225
233,305